Gastrointestinal Cancer

Genetic Testing Appears Cost Effective for Newly Diagnosed GIST
October 17, 2020

Researchers indicated that this economic evaluation supports the widespread adoption of standard genetic testing for newly diagnosed patients with metastatic gastrointestinal stromal tumors.

John L. Marshall, MD, on Accessibility of Precision Medicine
October 02, 2020

The expert from the Otto J. Ruesch Center for the Cure of Gastrointestinal Cancers discussed precision medicine with regard to cancer care, as well as the need to make such care more accessible for the global community.

Phase 3 ORIENT-32 Trial Shows Promise for First-Line Treatment Combo in HCC
September 28, 2020

The study is evaluating the efficacy and safety of sintilimab injection in combination with bevacizumab biosimilar injection compared to sorafenib in the first-line treatment of patients with advanced hepatocellular carcinoma.